Clinical trial
Validating Integrative Multi-omics Approaches in Metabolic Syndrome-related Diseases
Recruiting now · Not applicable · 1 countries · Registry ID NCT07248371
What this study is about
This study aims to validate integrative multi-omics approaches for understanding complications related to metabolic syndrome. By combining genetic, transcriptomic, metabolomic, and microbiome data from participants with and without metabolic syndrome, the research seeks to determine which biological factors predict disease progression and how these insights can inform precision prevention and treatment strategies for metabolic disorders.
Basic eligibility
Full registry criteria
Treatments and study arms
No intervention
no intervention
Primary outcomes
Comprehensive integration of genomic, transcriptomic, metabolomic, and microbiome datasets to identify molecular signatures predictive of metabolic syndrome progression and related complications (e.g., cardiovascular disease, chronic kidney disease, fatty liver).
Study locations
1 locations were listed when this page was built. The first 40 are shown.